Browse evidence-based analysis of health-related claims and assertions
Log in to see full claim details, scientific mechanisms, and cited studies.
For people with heart disease who are already taking cholesterol-lowering drugs, adding a medicine called evolocumab can cut their risk of heart attack, stroke, or dying from heart problems by 20%...
For people with heart disease who are already taking cholesterol-lowering drugs, adding a medicine called evolocumab can lower their chance of having a heart attack, stroke, or other serious heart...
Heart transplant patients taking PCSK9 inhibitor drugs don’t seem to develop harmful immune reactions to their new heart in the first month, which means their body isn’t showing early signs of...
For some people who've had a heart transplant, taking PCSK9 inhibitor drugs might help keep the inside of their heart's blood vessels from getting narrower over time.
If you've had a heart transplant and start taking a PCSK9 inhibitor for cholesterol, it probably won't mess with your anti-rejection medication levels.
People who got a new heart and took a drug called a PCSK9 inhibitor didn’t have serious side effects from the medicine — in fact, none of the 97 patients studied had problems caused by the drug over...
For people who've had a heart transplant and can't take cholesterol pills like statins, a newer medicine called a PCSK9 inhibitor might help lower their bad cholesterol by about 83 points over a year.
In healthy-looking middle-aged Americans with low heart disease risk, higher 'bad' cholesterol is linked to more buildup in heart arteries — and the more cholesterol, the more common these buildups...
Even if middle-aged Americans seem healthy and have low heart disease risk, over 30% still have hidden plaque in their arteries — and most of them have a heart scan score of zero, meaning standard...
Even in healthy middle-aged Americans with no calcium in their heart arteries, higher 'bad' cholesterol levels are linked to more plaque buildup in the heart's blood vessels.
Middle-aged Americans who feel fine but have high 'bad' cholesterol are more likely to have hidden heart artery plaque, especially if they already show signs of artery calcification — and those with...
Middle-aged adults who feel fine but have very high 'bad' cholesterol might be more likely to have hidden heart plaque, even if they don’t have symptoms.
Even if a heart scan shows no calcium buildup, nearly 3 in 10 middle-aged people with high 'bad' cholesterol still have soft plaque in their arteries — meaning the usual heart risk test might miss...
Even if middle-aged people have high cholesterol, nearly half of them might still have completely clean heart arteries, and over a third show no signs of plaque buildup — so high cholesterol doesn’t...
Even if someone has very high 'bad' cholesterol, more than half of middle-aged people with no symptoms still show no signs of heart artery buildup — meaning their bodies might be naturally protecting...
If a middle-aged person has very high 'bad' cholesterol but feels fine, they’re more than 2.6 times as likely to have early signs of heart artery buildup — even if everything else about their health...
High levels of PCSK9 in the blood are linked to higher heart attack risk and more dangerous plaque in arteries, even if cholesterol is controlled.
A type of cholesterol drug called PCSK9 inhibitors might help prevent blood clots by calming down overactive platelets, and this effect has been seen in people with a genetic form of high cholesterol...
PCSK9 doesn't just affect cholesterol—it also turns on inflammation switches in immune cells, which can damage blood vessels even if cholesterol is normal.
PCSK9 drugs don't just lower cholesterol—they can actually help shrink dangerous plaque buildup in heart arteries over time.
Drugs like alirocumab and evolocumab can lower bad cholesterol by more than half in people with a genetic cholesterol problem, and they keep working well for over a year with regular use.
People taking a cholesterol drug called evolocumab had almost twice as many heart failure deaths as those on a dummy pill in one big study, but this wasn’t mentioned in the main report—so scientists...
A second look at heart death data from a major drug trial found more heart-related deaths in the treatment group than were first reported, while the placebo group had fewer — suggesting the original...
People with heart disease who took a drug called evolocumab had more heart-related deaths than those who took a dummy pill, according to a reanalysis of a major study — but the difference wasn’t...